Loading clinical trials...
Loading clinical trials...
Phase II Study of First-line Single-agent Panitumumab in Frail Elderly Patients With Advanced Wild Type K-RAS Colorectal Cancer
Conditions
Interventions
Panitumumab
Locations
1
Spain
Spanish Cooperative Group for Gastrointestinal Tumour Therapy
Madrid, Spain
Start Date
May 1, 2010
Primary Completion Date
July 1, 2014
Completion Date
July 1, 2014
Last Updated
March 24, 2015
NCT06696768
NCT04704661
NCT05489211
NCT06625775
NCT04657068
NCT06445062
Lead Sponsor
Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions